Skip to main content
Recall Canary
Buprenorphine Sublingual Tablets 2 mg
← Back to all recallsDRUG RECALL

Buprenorphine Sublingual Tablets 2 mg

American Health Packaging recalls Buprenorphine Sublingual Tablets 2 mg over a label mix-up.

What to do

Consumers with the affected product should stop using it and contact American Health Packaging for instructions on returning the product or obtaining a replacement.

Recalled
Listed
Updated
Agency
FDA
Firm
American Health Packaging
Recall ID
99674
Status
ONGOING

Recall at a glance

Quantity recalled
10,953 cartons.

Why it was recalled

American Health Packaging is recalling Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, due to a label mix-up. The affected product is packaged in cartons with NDC 60687-481-21 and individual dose NDC 60687-481-11.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Buprenorphine Sublingual Tablets (C-III)

Lot code
1030023, 2027
Strength
2 mg
NDC / UPC
NDC 60687-481-11

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other Labeling Error recalls

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-09-01 · primary source: U.S. Food and Drug Administration